PhDSheilaDowdSheila Dowd349248Dowd, SheilaMy Scopus ID is 7101645788.
My NIH COMMONS name is SDOWD1.Associate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifierbibo:suffixNamename suffixAddressvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:overviewoverviewvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD003523Chemicals & Drugs2250.97426CycloserineD003865Disorders301070.920213Depressive Disorder, MajorAuthorship 37317731622374Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, Dowd S, Lewis M, Witcraft S, Pollack MH, Smits JAJPloS oneEffect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS One. 2019; 14(10):e0223729.PLoS One2019-10-17T00:00:002019Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.true1ProfessorProfessorBrianColeBrian Cole41.87352120000000-87.66713820000000349060Cole, BrianProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessorPsychiatryKernSinghKern Singh41.87352120000000-87.66713820000000349091Singh, KernAssociate ProfessorEileenMartinEileen M. Martin41.87724600000000-87.66843480000000349126Martin, EileenProfessorMarkPollackMark Pollack41.87724600000000-87.66843480000000349127Pollack, MarkProfessor1116selected publications0.815040.010550469research areas1.178290.01475752coauthor of18.24950.96014560similar totrue1Assistant ProfessorAssistant ProfessorShaneNhoShane Nho41.87352120000000-87.66713820000000349741Nho, ShaneAssistant ProfessorAuthorship 100313Authorship 38402Authorship 438586Assistant Professor5Associate Professor4ProfessorAuthorship 50904Authorship 671916Authorship 67843Authorship 86412Authorship 8779312804681Martis B, Alam D, Dowd SM, Hill SK, Sharma RP, Rosen C, Pliskin N, Martin E, Carson V, Janicak PGClinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologyNeurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol. 2003 Jun; 114(6):1125-32.Clin Neurophysiol2003-06-01T00:00:002003Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression.12845398Negrusz A, Bowen AM, Moore CM, Dowd SM, Strong MJ, Janicak PGAnalytical and bioanalytical chemistryElimination of 7-aminoclonazepam in urine after a single dose of clonazepam. Anal Bioanal Chem. 2003 Aug; 376(8):1198-204.Anal Bioanal Chem2003-07-04T00:00:002003Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam.Authorship 38881132257848Dowd SM, Zalta AK, Burgess HJ, Adkins EC, Valdespino-Hayden Z, Pollack MHWorld journal of psychiatryDouble-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19; 10(3):21-28.World J Psychiatry2020-03-19T00:00:002020Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia.17606665Janicak PG, Dowd S, Rado J, Welch MJ, Fogg L, O'Reardon J, Avery D, Coffey CE, Sampson S, Boutros NThe American journal of psychiatryRepetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression. Am J Psychiatry. 2007 Jul; 164(7):1118; author reply 1118-9.Am J Psychiatry2007-07-01T00:00:002007Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression.20965447Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AFBrain stimulationDurability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010 Oct; 3(4):187-99.Brain Stimul2010-08-11T00:00:002010Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.21951987Wall CA, Croarkin PE, Sim LA, Husain MM, Janicak PG, Kozel FA, Emslie GJ, Dowd SM, Sampson SMThe Journal of clinical psychiatryAdjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry. 2011 Sep; 72(9):1263-9.J Clin Psychiatry2011-09-01T00:00:002011Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study.24038728Zalta AK, Dowd S, Rosenfield D, Smits JA, Otto MW, Simon NM, Meuret AE, Marques L, Hofmann SG, Pollack MHDepression and anxietySleep quality predicts treatment outcome in CBT for social anxiety disorder. Depress Anxiety. 2013 Nov; 30(11):1114-20.Depress Anxiety2013-08-26T00:00:002013Sleep quality predicts treatment outcome in CBT for social anxiety disorder.26708778Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MSBrain stimulationCan Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul. 2016 Mar-Apr; 9(2):251-7.Brain Stimul2015-11-25T00:00:002015Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.27315514Otto MW, Pollack MH, Dowd SM, Hofmann SG, Pearlson G, Szuhany KL, Gueorguieva R, Krystal JH, Simon NM, Tolin DFDepression and anxietyRANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depress Anxiety. 2016 08; 33(8):737-45.Depress Anxiety2016-06-17T00:00:002016RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.Authorship 39582532496566Smits JAJ, Pollack MH, Rosenfield D, Otto MW, Dowd S, Carpenter J, Dutcher CD, Lewis EM, Witcraft SM, Papini S, Curtiss J, Andrews L, Kind S, Conroy K, Hofmann SGJAMA network openDose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e206777.JAMA Netw Open2020-06-01T00:00:002020Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.D007171Procedures3160.981157Implosive TherapyD050781Procedures9170.988496Transcranial Magnetic StimulationNeurological SciencesOrthopedic SurgeryRush University, Rush Medical CollegeDavidBennettDavid A. Bennett41.87328300000000-87.66936330000000349004Bennett, DavidProfessorAuthorship 42288234010494Dutcher CD, Dowd SM, Zalta AK, Taylor DJ, Rosenfield D, Perrone A, Otto MW, Pollack MH, Hofmann SG, Smits JAJDepression and anxietySleep quality and outcome of exposure therapy in adults with social anxiety disorder. Depress Anxiety. 2021 11; 38(11):1182-1190.Depress Anxiety2021-05-19T00:00:002021Sleep quality and outcome of exposure therapy in adults with social anxiety disorder.true1Associate ProfessorAssociate ProfessorAuthorship 241464Authorship 25621311941029Janicak PG, Easton MS, Comaty JE, Dowd S, Davis JMConvulsive therapyEfficacy of ECT in Psychotic and Nonpsychotic Depression. Convuls Ther. 1989; 5(4):314-320.Convuls Ther1989-01-01T00:00:001989Efficacy of ECT in Psychotic and Nonpsychotic Depression.27320180Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MSBrain stimulationErratum to "Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study" [Brain Stimulation 9 (2016) 251-257]. Brain Stimul. 2016 Jul-Aug; 9(4):639.Brain Stimul2016-03-29T00:00:002016Erratum to "Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study" [Brain Stimulation 9 (2016) 251-257].true1ProfessorProfessorAuthorship 46980737399757Lubin RE, Fitzgerald HE, Rosenfield D, Carpenter JK, Papini S, Dutcher CD, Dowd SM, Hofmann SG, Pollack MH, Smits JAJ, Otto MWJournal of psychiatric researchUsing pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT. J Psychiatr Res. 2023 08; 164:357-363.J Psychiatr Res2023-06-19T00:00:002023Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT.Authorship 48753337979218Taylor CT, Rosenfield D, Dowd SM, Dutcher CD, Hofmann SG, Otto MW, Pollack MH, Smits JAJBehaviour research and therapyWhat good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder. Behav Res Ther. 2023 12; 171:104436.Behav Res Ther2023-11-11T00:00:002023What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder.D0000728613120.988988Phobia, Social